Biocon subsidiary acquires research facility from Pfizer Healthcare

Biocon Biologics has acquired research and development (RD) capital assets of a 60,000-square feet research facility at Ticel Bio Park in Chennai, Biocon said in a statement.

from Moneycontrol Business News https://ift.tt/2kFst2s